Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Object Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | CLEC6A | Human | (-)-alpha-phellandrene | decreases expression | EXP | | 6480464 | alpha phellandrene results in decreased expression of CLEC4N mRNA | CTD | PMID:25075043 | CLEC6A | Human | (1->4)-beta-D-glucan | multiple interactions | ISO | Clec4n (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of CLEC4N mRNA | CTD | PMID:36331819 | CLEC6A | Human | 1,1-dichloroethene | increases expression | ISO | Clec4n (Mus musculus) | 6480464 | vinylidene chloride results in increased expression of CLEC4N mRNA | CTD | PMID:26682919 | CLEC6A | Human | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | Clec4n (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of CLEC4N mRNA | CTD | PMID:26377647 and PMID:28922406 | CLEC6A | Human | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | Clec4n (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin results in increased expression of CLEC4N mRNA | CTD | PMID:26290441 | CLEC6A | Human | 2,4-dibromophenyl 2,4,5-tribromophenyl ether | affects expression | ISO | Clec4n (Mus musculus) | 6480464 | 2 more ... | CTD | PMID:38648751 | CLEC6A | Human | 4-hydroxynon-2-enal | decreases expression | ISO | Clec4n (Mus musculus) | 6480464 | 4-hydroxy-2-nonenal results in decreased expression of CLEC4N mRNA | CTD | PMID:19191707 | CLEC6A | Human | 4-hydroxyphenyl retinamide | increases expression | ISO | Clec4n (Mus musculus) | 6480464 | Fenretinide results in increased expression of CLEC6A mRNA | CTD | PMID:28973697 | CLEC6A | Human | aldehydo-D-glucose | multiple interactions | ISO | Clec4n (Mus musculus) | 6480464 | [lard co-treated with Cholesterol and Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of CLEC4N mRNA | CTD | PMID:37567420 | CLEC6A | Human | all-trans-retinoic acid | increases expression | EXP | | 6480464 | Tretinoin results in increased expression of CLEC6A mRNA | CTD | PMID:33167477 | CLEC6A | Human | alpha-phellandrene | decreases expression | EXP | | 6480464 | alpha phellandrene results in decreased expression of CLEC4N mRNA | CTD | PMID:25075043 | CLEC6A | Human | benzo[a]pyrene | increases expression | ISO | Clec4n (Mus musculus) | 6480464 | Benzo(a)pyrene results in increased expression of CLEC4N mRNA | CTD | PMID:22228805 | CLEC6A | Human | benzo[a]pyrene | multiple interactions | ISO | Clec4n (Mus musculus) | 6480464 | AHR protein affects the reaction [Benzo(a)pyrene affects the expression of CLEC4N mRNA] | CTD | PMID:22228805 | CLEC6A | Human | benzo[b]fluoranthene | increases expression | ISO | Clec4n (Mus musculus) | 6480464 | benzo(b)fluoranthene results in increased expression of CLEC4N mRNA | CTD | PMID:26377693 | CLEC6A | Human | Benzo[k]fluoranthene | increases expression | ISO | Clec4n (Mus musculus) | 6480464 | benzo(k)fluoranthene results in increased expression of CLEC4N mRNA | CTD | PMID:26377693 | CLEC6A | Human | bisphenol A | increases expression | ISO | Clec4n (Mus musculus) | 6480464 | bisphenol A results in increased expression of CLEC4N mRNA | CTD | PMID:32156529 | CLEC6A | Human | bisphenol F | multiple interactions | EXP | | 6480464 | [bisphenol F co-treated with Fulvestrant] results in decreased methylation of CLEC6A gene | CTD | PMID:31601247 | CLEC6A | Human | carbon nanotube | increases expression | ISO | Clec4n (Mus musculus) | 6480464 | Nanotubes more ... | CTD | PMID:25554681 and PMID:25620056 | CLEC6A | Human | choline | multiple interactions | ISO | Clec4n (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of CLEC4N mRNA | CTD | PMID:20938992 | CLEC6A | Human | D-glucose | multiple interactions | ISO | Clec4n (Mus musculus) | 6480464 | [lard co-treated with Cholesterol and Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of CLEC4N mRNA | CTD | PMID:37567420 | CLEC6A | Human | diclofenac | increases expression | ISO | Clec4n (Mus musculus) | 6480464 | Diclofenac results in increased expression of CLEC4N mRNA | CTD | PMID:26934552 | CLEC6A | Human | doxorubicin | increases expression | ISO | Clec4n (Mus musculus) | 6480464 | Doxorubicin results in increased expression of CLEC4N mRNA | CTD | PMID:36227756 | CLEC6A | Human | epoxiconazole | increases expression | ISO | Clec4n (Mus musculus) | 6480464 | epoxiconazole results in increased expression of CLEC4N mRNA | CTD | PMID:35436446 | CLEC6A | Human | ethanol | multiple interactions | ISO | Clec4n (Mus musculus) | 6480464 | [Carbon Tetrachloride co-treated with Ethanol] results in increased expression of CLEC4N mRNA | CTD | PMID:30517762 | CLEC6A | Human | folic acid | multiple interactions | ISO | Clec4n (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of CLEC4N mRNA | CTD | PMID:20938992 | CLEC6A | Human | fructose | multiple interactions | ISO | Clec4n (Mus musculus) | 6480464 | [lard co-treated with Cholesterol and Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of CLEC4N mRNA | CTD | PMID:37567420 | CLEC6A | Human | fulvestrant | multiple interactions | EXP | | 6480464 | [bisphenol F co-treated with Fulvestrant] results in decreased methylation of CLEC6A gene | CTD | PMID:31601247 | CLEC6A | Human | glucose | multiple interactions | ISO | Clec4n (Mus musculus) | 6480464 | [lard co-treated with Cholesterol and Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of CLEC4N mRNA | CTD | PMID:37567420 | CLEC6A | Human | glyphosate | multiple interactions | ISO | Clec4n (Mus musculus) | 6480464 | [lard co-treated with Cholesterol and Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of CLEC4N mRNA | CTD | PMID:37567420 | CLEC6A | Human | isoprenaline | increases expression | ISO | Clec4n (Mus musculus) | 6480464 | Isoproterenol results in increased expression of CLEC4N mRNA | CTD | PMID:20003209 | CLEC6A | Human | L-methionine | multiple interactions | ISO | Clec4n (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of CLEC4N mRNA | CTD | PMID:20938992 | CLEC6A | Human | lead diacetate | increases expression | ISO | Clec4n (Mus musculus) | 6480464 | lead acetate results in increased expression of CLEC4N mRNA | CTD | PMID:20542052 | CLEC6A | Human | lipopolysaccharide | increases expression | ISO | Clec4n (Mus musculus) | 6480464 | Lipopolysaccharides results in increased expression of CLEC4N mRNA | CTD | PMID:21461237 and PMID:27339419 | CLEC6A | Human | lipopolysaccharide | multiple interactions | ISO | Clec4n (Mus musculus) | 6480464 | Melatonin inhibits the reaction [Lipopolysaccharides results in increased expression of CLEC4N mRNA] | CTD | PMID:21461237 | CLEC6A | Human | melatonin | multiple interactions | ISO | Clec4n (Mus musculus) | 6480464 | Melatonin inhibits the reaction [Lipopolysaccharides results in increased expression of CLEC4N mRNA] | CTD | PMID:21461237 | CLEC6A | Human | melatonin | decreases expression | ISO | Clec4n (Mus musculus) | 6480464 | Melatonin results in decreased expression of CLEC4N mRNA | CTD | PMID:21461237 | CLEC6A | Human | Monobutylphthalate | decreases expression | ISO | Clec6a-ps1 (Rattus norvegicus) | 6480464 | monobutyl phthalate results in decreased expression of CLEC6A mRNA | CTD | PMID:29162477 | CLEC6A | Human | ozone | increases expression | ISO | Clec4n (Mus musculus) | 6480464 | Ozone results in increased expression of CLEC4N mRNA | CTD | PMID:19555225 | CLEC6A | Human | ozone | multiple interactions | ISO | Clec4n (Mus musculus) | 6480464 | [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of CLEC4N mRNA more ... | CTD | PMID:25658374 more ... | CLEC6A | Human | paracetamol | affects expression | ISO | Clec4n (Mus musculus) | 6480464 | Acetaminophen affects the expression of CLEC4N mRNA | CTD | PMID:17562736 | CLEC6A | Human | paraquat | affects expression | EXP | | 6480464 | Paraquat affects the expression of CLEC6A mRNA | CTD | PMID:34097952 | CLEC6A | Human | perfluorohexanesulfonic acid | increases expression | ISO | Clec4n (Mus musculus) | 6480464 | perfluorohexanesulfonic acid results in increased expression of CLEC4N mRNA | CTD | PMID:37995155 | CLEC6A | Human | perfluorooctane-1-sulfonic acid | multiple interactions | ISO | Clec4n (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of CLEC4N mRNA | CTD | PMID:36331819 | CLEC6A | Human | rotenone | increases expression | ISO | Clec4n (Mus musculus) | 6480464 | Rotenone results in increased expression of CLEC4N mRNA | CTD | PMID:32937126 | CLEC6A | Human | silicon dioxide | increases expression | ISO | Clec4n (Mus musculus) | 6480464 | Silicon Dioxide results in increased expression of CLEC4N mRNA | CTD | PMID:29341224 | CLEC6A | Human | silicon dioxide | increases expression | ISO | Clec6a-ps1 (Rattus norvegicus) | 6480464 | Silicon Dioxide results in increased expression of CLEC6A-PS1 mRNA | CTD | PMID:34779285 | CLEC6A | Human | succimer | multiple interactions | ISO | Clec4n (Mus musculus) | 6480464 | [Succimer binds to Magnetite Nanoparticles] which results in increased expression of CLEC4N mRNA | CTD | PMID:21641980 | CLEC6A | Human | tetrachloromethane | increases expression | ISO | Clec4n (Mus musculus) | 6480464 | Carbon Tetrachloride results in increased expression of CLEC4N mRNA | CTD | PMID:27339419 and PMID:31919559 | CLEC6A | Human | tetrachloromethane | multiple interactions | ISO | Clec4n (Mus musculus) | 6480464 | [Carbon Tetrachloride co-treated with Ethanol] results in increased expression of CLEC4N mRNA | CTD | PMID:30517762 | CLEC6A | Human | titanium dioxide | increases expression | ISO | Clec4n (Mus musculus) | 6480464 | titanium dioxide results in increased expression of CLEC4N mRNA | CTD | PMID:23557971 and PMID:27760801 | CLEC6A | Human | tremolite asbestos | increases expression | ISO | Clec4n (Mus musculus) | 6480464 | tremolite results in increased expression of CLEC4N mRNA | CTD | PMID:29279043 | |